Indication
Acute Fatal Form
1 clinical trial
2 products
Clinical trial
Study of Therapeutic Plasma Exchange, Rituximab and Intravenous Immunoglobulin for Acute Exacerbations of Idiopathic Pulmonary Fibrosis (STRIVE-IPF)Status: Recruiting, Estimated PCD: 2024-08-01
Product
Treatment as Usual